EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Obstructive sleep apnea, lipoprotein(a) and long-term cardiovascular outcomes in acute coronary syndrome

Wen Hao, Yuyao Qiu, Zekun Zhang, Bin Wang, Wei Gong, Wen Zheng, Hui Wang iD, Lei Xu iD, Shaoping Nie, Xiao Wang

SLEEP · 15.06.2026 · 49 (6)

DOI: 10.1093/sleep/zsag062 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift SLEEP, online erschienen am 06.03.2026. Verfasst von Wen Hao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, C…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Lipoprotein(a), Sleep Apnea, Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Key R&D Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objectives The impact of obstructive sleep apnea (OSA) on subsequent cardiovascular events in patients with acute coronary syndrome (ACS) remains debated. This study aims to investigate whether the association of OSA with cardiovascular events is affected by lipoprotein (a) [Lp(a)] levels.

Methods

This is a sub-analysis of prospective cohort study (OSA-ACS, NCT03362385) enrolled ACS patients. OSA defined as an apnea-hypopnea index ≥15 events/h. The effects of OSA on subsequent cardiovascular outcomes were evaluated across varying Lp(a) thresholds. Coronary plaque features by coronary computed tomography angiography were also analyzed.

Results

A total of 1137 patients were enrolled, 608 patients (53.5%) were diagnosed with OSA. At a median follow-up of 3.6 years, OSA was associated with a higher risk of major adverse cardiovascular and cerebrovascular events (MACCE) in patients with Lp(a) level >median (HR 1.59, 95% CI 1.12-2.26, P=0.009), but not in patients with Lp(a) level ≤median (HR 1.09, 95% CI 0.80-1.49, P=0.60). There were consistent increases in HRs for MACCE in the OSA group with Lp(a) levels rising, as stratified by tertiles or quartiles of Lp(a). In patients with Lp(a) level >median, OSA demonstrated a higher prevalence of ≥1 high-risk plaque (HRP) feature (51.4% vs. 33.3%, P=0.03) and low-attenuation plaque (50.0% vs. 32.8, P=0.04) per vessel than non-OSA.

Conclusion

OSA was associated with a continuously increased cardiovascular risk and a higher prevalence of HRP features as Lp(a) levels rose. Lp(a) may help identify ACS patients at higher cardiovascular risk, in whom the efficacy of OSA treatment should be further investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeLipoprotein(a)Sleep Apnea, ObstructiveAgedFemaleHumansMaleMiddle AgedProspective StudiesRisk Factors

Stichwörter der Autor:innen

acute coronary syndromecoronary computed tomography angiographylipoprotein (a)obstructive sleep apnea

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University, Beijing, China.
  • Education Department, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Division of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
  • Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
  • International Hospital, Peking University, Beijing, China.

ORCID-Profile: Hui Wang, Lei Xu

Förderung

  • Beijing Natural Science Foundation
  • National Key R&D Program of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Hao, W., Qiu, Y., Zhang, Z., Wang, B., Gong, W., Zheng, W., Wang, H., Xu, L., Nie, S., & Wang, X. (2026). Obstructive sleep apnea, lipoprotein(a) and long-term cardiovascular outcomes in acute coronary syndrome. SLEEP, 49(6). https://doi.org/10.1093/sleep/zsag062

Vancouver

Hao W, Qiu Y, Zhang Z, Wang B, Gong W, Zheng W, et al. Obstructive sleep apnea, lipoprotein(a) and long-term cardiovascular outcomes in acute coronary syndrome. SLEEP. 2026;49(6). doi:10.1093/sleep/zsag062

BibTeX
@article{Hao2026,
  author = {Hao, Wen and Qiu, Yuyao and Zhang, Zekun and Wang, Bin and Gong, Wei and Zheng, Wen and Wang, Hui and Xu, Lei and Nie, Shaoping and Wang, Xiao},
  title = {Obstructive sleep apnea, lipoprotein(a) and long-term cardiovascular outcomes in acute coronary syndrome},
  journal = {SLEEP},
  year = {2026},
  volume = {49},
  number = {6},
  doi = {10.1093/sleep/zsag062}
}
Kostenlos starten →